Results 281 to 290 of about 80,577 (303)

Janus Kinase

2006
openaire   +2 more sources

Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis

Journal of Dermatological Treatment, 2022
Kevin Phan, Steven Phan, Stephen Shumack   +2 more
exaly  

Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases

Pharmacological Research, 2016
Robert Roskoski
exaly  

Development of new pyrrolopyrimidine-based inhibitors of Janus kinase 3 (JAK3)

Bioorganic and Medicinal Chemistry Letters, 2007
Michael P Clark, Roger G Bookland, Adam Golebiowski   +2 more
exaly  

Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature

Journal of Dermatological Treatment, 2017
Aniseh Samadi, Saman Ahmad Nasrollahi, Ashkan Hashemi   +2 more
exaly  

Janus Kinase

2011
openaire   +1 more source

Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis

Clinical and Experimental Immunology, 2014
K Migita, Migita K, Kawakami A
exaly  

Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure

Journal of the American Academy of Dermatology, 2017
Lucy Y Liu, James P Strassner, John E Harris   +2 more
exaly  

Janus Kinases

2008
openaire   +1 more source

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib

Journal of the American Academy of Dermatology, 2017
Brooke E Rothstein, Deep Joshipura, Rana Abdat   +2 more
exaly